Insights about
Compliance, Validation & Risk

NIS2 makes resilience in the pharmaceutical industry a strategic leadership priority, requiring an integrated operating model that harmonizes compliance, cybersecurity, and business continuity.

Organizations succeed by applying established validation principles pragmatically and focusing on end-to-end data integrity.

Getting a researched-based pharmaceutical and biotech company ready for the FDA.

Compliance by Design enables successful pharma CRM – compliant, efficient and ready for true omnichannel engagement.

How a globally operation NGO realigned the product strategy for its digital medicine application with the help of msg industry advisors.

Cloud-based data lakes, warehouses, and pipelines can also be used in GxP-regulated environments — with proper qualification and validation.

Creating a new MES landscape for a research-based pharmaceutical and biotech company.

To effectively minimize compliance risks, it is not enough to treat individual symptoms. Effective digitalization is required.